PMV Pharmaceuticals, Inc. (PMVP)

NASDAQ: PMVP · Real-Time Price · USD

Compare

1.020

-0.010 (-0.97%)

At close: Feb 5, 2026, 4:00 PM EST

1.030

+0.010 (0.95%)

After-hours: Feb 5, 2026, 4:16 PM EST

PMV Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	36.34	40.88	37.71	108.3	172.47	361.42
Short-Term Investments	92.91	128.58	165.35	132.76	124.7	-
Cash & Short-Term Investments	129.25	169.45	203.06	241.05	297.16	361.42
Cash Growth	-29.31%	-16.55%	-15.76%	-18.88%	-17.78%	256.13%
Prepaid Expenses	3.2	6.2	3.53	5.13	3.3	3.34
Restricted Cash	-	-	0.82	0.82	0.82	-
Total Current Assets	132.45	175.66	207.41	247.01	301.29	364.76
Property, Plant & Equipment	1.15	1.55	19.05	20.49	13.15	0.57
Long-Term Investments	-	13.84	25.51	2.5	16.91	-
Other Long-Term Assets	0.25	0.24	0.19	0.31	0.22	0.2
Total Assets	133.84	191.29	252.15	270.31	331.57	365.53
Accounts Payable	3.4	6.58	3.24	3	3.19	1.61
Accrued Expenses	8.52	7.44	9.94	7.31	8.63	4.8
Current Portion of Leases	0.39	0.35	0.85	0.53	0.4	-
Total Current Liabilities	12.3	14.37	14.03	10.83	12.22	6.41
Long-Term Leases	0.54	0.84	12.43	13.45	10.79	-
Total Liabilities	12.85	15.21	26.46	24.28	23.01	6.41
Additional Paid-In Capital	549.33	544.65	535.47	487.52	476.36	469
Retained Earnings	-428.42	-368.71	-310	-241.04	-167.73	-109.88
Comprehensive Income & Other	0.09	0.14	0.22	-0.45	-0.08	-
Total Common Equity	121	176.08	225.69	246.03	308.56	359.12
Shareholders' Equity	121	176.08	225.69	246.03	308.56	359.12
Total Liabilities & Equity	133.84	191.29	252.15	270.31	331.57	365.53
Total Debt	0.93	1.19	13.29	13.98	11.19	-
Net Cash (Debt)	128.32	182.11	215.28	229.57	302.88	361.42
Net Cash Growth	-30.51%	-15.41%	-6.23%	-24.20%	-16.20%	256.13%
Net Cash Per Share	2.46	3.53	4.48	5.04	6.71	25.16
Filing Date Shares Outstanding	53.21	51.93	51.44	45.77	45.45	44.78
Total Common Shares Outstanding	52.99	51.94	51.45	45.77	45.43	44.78
Working Capital	120.15	161.29	193.38	236.17	289.07	358.35
Book Value Per Share	2.28	3.39	4.39	5.38	6.79	8.02
Tangible Book Value	121	176.08	225.69	246.03	308.56	359.12
Tangible Book Value Per Share	2.28	3.39	4.39	5.38	6.79	8.02
Machinery	1.48	1.82	3.17	2.53	2.28	2.01
Leasehold Improvements	0.07	0.05	10.77	0.41	0.16	0.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q